| Autor: |
Tintu Varghese, Shainey Alokit Khakha, Sidhartha Giri, Nayana P. Nair, Manohar Badur, Geeta Gathwala, Sanjeev Chaudhury, Shayam Kaushik, Mrutunjay Dash, Nirmal K. Mohakud, Rajib K. Ray, Prasantajyoti Mohanty, Chethrapilly Purushothaman Girish Kumar, Seshadri Venkatasubramanian, Rashmi Arora, Venkata Raghava Mohan, Jacqueline E. Tate, Umesh D. Parashar, Gagandeep Kang |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Pathogens, Vol 10, Iss 4, p 416 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2076-0817 |
| DOI: |
10.3390/pathogens10040416 |
| Popis: |
In April 2016, an indigenous monovalent rotavirus vaccine (Rotavac) was introduced to the National Immunization Program in India. Hospital-based surveillance for acute gastroenteritis was conducted in five sentinel sites from 2012 to 2020 to monitor the vaccine impact on various genotypes and the reduction in rotavirus positivity at each site. Stool samples collected from children under 5 years of age hospitalized with diarrhea were tested for group A rotavirus using a commercial enzyme immunoassay, and rotavirus strains were characterized by RT-PCR. The proportion of diarrhea hospitalizations attributable to rotavirus at the five sites declined from a range of 56–29.4% in pre-vaccine years to 34–12% in post-vaccine years. G1P[8] was the predominant strain in the pre-vaccination period, and G3P[8] was the most common in the post-vaccination period. Circulating patterns varied throughout the study period, and increased proportions of mixed genotypes were detected in the post-vaccination phase. Continuous long-term surveillance is essential to understand the diversity and immuno-epidemiological effects of rotavirus vaccination. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
